Esrum Biotech ApS — Credit Rating and Financial Key Figures
CVR number: 43131761
Søparken 7, Nødebo 3480 Fredensborg
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 1 458.92 | 2 008.74 |
| Employee benefit expenses | -72.00 | - 126.00 |
| EBIT | 1 386.92 | 1 882.74 |
| Other financial income | 6.95 | |
| Other financial expenses | -2.97 | -17.55 |
| Pre-tax profit | 1 383.95 | 1 872.15 |
| Income taxes | - 304.55 | - 413.91 |
| Net earnings | 1 079.40 | 1 458.24 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Current trade debtors | 219.73 | 58.06 |
| Prepayments and accrued income | 0.25 | |
| Current other receivables | 9.04 | |
| Short term receivables total | 219.98 | 67.10 |
| Cash and bank deposits | 1 162.61 | 2 977.29 |
| Cash and cash equivalents | 1 162.61 | 2 977.29 |
| Balance sheet total (assets) | 1 382.59 | 3 044.39 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Shares repurchased | 190.67 | |
| Retained earnings | - 190.67 | 888.74 |
| Profit of the financial year | 1 079.40 | 1 458.24 |
| Shareholders equity total | 1 119.40 | 2 386.97 |
| Non-current liabilities total | ||
| Current bonds | 107.70 | 216.40 |
| Current owed to participating | 0.94 | 27.11 |
| Short-term deferred tax liabilities | 154.55 | 413.91 |
| Current liabilities total | 263.18 | 657.42 |
| Balance sheet total (liabilities) | 1 382.59 | 3 044.39 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.